WCN24-2220 A DOUBLE HIT: CASE OF THROMBOTIC MICROANGIOPATHY CONCURRENT WITH MEMBRANOUS NEPHROPATHY IN A PATIENT WITH MYELOPROLIFERATIVE NEOPLASM

WCN24-2220 A DOUBLE HIT: CASE OF THROMBOTIC MICROANGIOPATHY CONCURRENT WITH MEMBRANOUS NEPHROPATHY IN A PATIENT WITH MYELOPROLIFERATIVE NEOPLASM

Saved in:

Bibliographic Details
Main Author:	Yuliya Sharakova
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924002419
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Fabrizio Vianello, et al.
Published: (2011-01-01)

WCN25-1181 REVISITING “THE CHAMELEON”: THROMBOTIC MICROANGIOPATHY, CLINICAL PROFILE OF PATIENTS WITH THROMBOTIC MICROANGIOPATHY: SINGLE CENTER EXPERIENCE
by: Suvika Patel, et al.
Published: (2025-02-01)

WCN24-387 C3 GLOMERULONEPHRITIS AND THROMBOTIC MICROANGIOPATHY - A PROSPECTIVE OBSERVATIONAL STUDY
by: Mythri Shankar, et al.
Published: (2024-04-01)

WCN24-2607 THROMBOTIC MICROANGIOPATHY AND KIDNEY TRANSPLANTATION (KT). A SINGLE CENTER EXPERIENCE
by: Alejandra Ines Espinoza, et al.
Published: (2024-04-01)

WCN24-1045 THROMBOTIC MICROANGIOPATHY IN A RENAL ALLOGRAFT: CAPABILITIES AND LIMITATIONS OF PATHOLOGICAL DIAGNOSIS
by: Ekaterina Stoliarevich, et al.
Published: (2024-04-01)

WCN24-1408 REJECTION MEDIATED BY NON-HLA ANTIBODY AND THROMBOTIC MICROANGIOPATHY. CLINICAL CASE
by: Jacqueline pefaur, et al.
Published: (2024-04-01)

Thrombotic microangiopathy in IgA nephropathy: pathophysiology, histopathology, and treatment perspectives
by: Ali Rastegar-Kashkouli, et al.
Published: (2024-05-01)

Monoclonal immunoglobulinemia of renal significance with concurrent thrombotic microangiopathy： one case report
by: Wang Mian, et al.
Published: (2022-09-01)

WCN25-2896 THROMBOTIC MICROANGIOPATHY IN PREGNANCY:A DECEPTIVE ADVERSARY
by: adrija chatterjee, et al.
Published: (2025-02-01)

Granulocytic Expression of CD11b/CD18 and Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Doroteya Todorieva-Todorova, et al.
Published: (2021-06-01)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01)

WCN25-2220 PROPORTION OF RAPID PROGRESSION OF DIABETIC NEPHROPATHY AND THE FACTORS ASSOCIATED WITH IT AMONG PATIENTS ATTENDING A TERTIARY CARE CENTRE IN SOUTH INDIA
by: Gayathri Pillai, et al.
Published: (2025-02-01)

WCN24-1082 CASE REPORT. THROMBOTIC MICROANGIOPATHY SECONDARY BY MIXED CONNECTIVE TISSUE DISEASE POST-COVID-19 VACCINATION
by: Andrea Portilla, et al.
Published: (2024-04-01)

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01)

Thrombotic microangiopathy after kidney transplantion
by: Mohammad Sami Tahseen, et al.
Published: (2023-12-01)

Primary Thrombotic Microangiopathy in Pediatric Patients
by: Andrés David Aranzazu Ceballos MD, et al.
Published: (2024-12-01)

WCN24-2117 AN UNCOMMON CAUSE OF THROMBOTIC MICROANGIOPATHY IN A CHILD WITH SPINAL MUSCULAR ATROPHY TYPE 1: A CASE REPORT
by: Sofia Escande, et al.
Published: (2024-04-01)

WCN25-270 POSTPARTUM RENAL CORTICAL NECROSIS IS ASSOCIATED WITH DISTINCT THROMBOTIC MICROANGIOPATHY SYNDROME
by: Adarsh Kumar, et al.
Published: (2025-02-01)

WCN24-1739 MALIGNANT ARTERIAL HYPERTENSION (MAH): THE OLDEST CAUSE OF THROMBOTIC MICROANGIOPATHY THAT IS A MEDICAL DIAGNOSIS CHALLENGE. A CASE REPORT
by: Eduardo Salgado, et al.
Published: (2024-04-01)

“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-04-01)

Clinical case of thrombotic microangiopathy in obstetric practice
by: M. N. Mochalova, et al.
Published: (2017-06-01)

Progress in the pathogenesis， diagnosis and treatment of thrombotic microangiopathy
by: Yang Xiao-yu, et al.
Published: (2025-04-01)

Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy Subtypes
by: Hannah Beckwith, et al.
Published: (2025-06-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE
by: Hillard Michael Lazarus, et al.
Published: (2010-08-01)

Renal Thrombotic Microangiopathy due to Hypertensive Emergency
by: Evan Perona, et al.
Published: (2025-01-01)

Toward a Revised Definition of Thrombotic Microangiopathy
by: Sjoerd A.M.E.G. Timmermans, et al.
Published: (2025-06-01)

Clinicopathological Spectrum and Treatment Outcome of Thrombotic Microangiopathy
by: Sarang Vijayan, et al.
Published: (2023-04-01)

The outcome of thrombotic microangiopathy in kidney transplant recipients
by: Kanza Haq, et al.
Published: (2024-11-01)

WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
by: Hiddo J.L. Heerspink, et al.
Published: (2024-04-01)

Rare Case of Congenital Thrombotic Thrombocytopenic Purpura Presenting as Posttransplant Thrombotic Microangiopathy
by: Akila Viswanathan, et al.
Published: (2024-12-01)

A novel heterozygous mutation in the gelsolin gene causes Finnish gelsolin amyloidosis associated with nephropathy and thrombotic microangiopathy
by: Hong Liang, et al.
Published: (2025-02-01)

Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy
by: Seby R, et al.
Published: (2025-07-01)

A case of renal thrombotic microangiopathy caused by Bevacizumab
by: LIAO Bing, et al.
Published: (2020-01-01)

Thrombotic Microangiopathy Complicating Cyclosporine in Renal Transplant Patients
by: Safa Al-Mukhtar
Published: (2023-04-01)

Transplant-associated Thrombotic Microangiopathy: An Enigma Treated with Eculizumab
by: S. Ravitej, et al.
Published: (2024-10-01)

Comprehensive Analysis of Thrombotic Microangiopathy Following Renal Transplantation
by: Ittai Fattal, et al.
Published: (2024-01-01)

Thrombotic Microangiopathy From Peptide Receptor Radionuclide Therapy
by: Paul Delalande, et al.
Published: (2025-02-01)

Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies
by: Manuel Urra, et al.
Published: (2024-08-01)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
by: Sylvie Hermouet, et al.
Published: (2015-01-01)